首页> 外文期刊>Human Genetics >Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.
【24h】

Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.

机译:在患有无症状的肌营养不良症的患者中,深层肌营养不良蛋白基因的内含子2内深处的隐蔽剪接受体位点的激活可能导致两个替代性外显子。

获取原文
获取原文并翻译 | 示例
           

摘要

Intron 2 of the dystrophin gene is unusually large, extending 157 kb on the X-chromosome, and is known to contain one cryptic exon 2a. Here, we report that a single nucleotide change in the middle of this huge intron is a source of two novel extra exons. A novel point mutation changing T to A nucleotide was identified at 5591 bp downstream from the 3' end of exon 2 (T310+5591A) in genomic DNA of an asymptomatic dystrophinopathy case. The mutation identification was initiated by detection of two novel dystrophin mRNAs containing a 132-nucleotide or 46-nucleotide insertion between exons 2 and 3 in lymphocytes but one with a 132-nucleotide insertion in skeletal muscle. It was concluded that T310+5591A created a novel consensus sequence for a splice acceptor site leading to the formation of two novel exon structures by using two cryptic splice donor sites at 132 bp or 46 bp downstream. The former maintained the dystrophin reading frame and was expected to insert 44 amino acids in the N-terminal domain of dystrophin, whereas the latter created a premature stop codon. An immunohistochemical study of the skeletal muscle of the patient disclosed that the N-terminal domain of dystrophin was not stained, but the rod- and C-terminal domains were stained in a patchy and discontinuous manner, indicating that the in-frame mRNA was functional. Creation of a splice acceptor site by a single nucleotide change leading to extra exon structures is a novel molecular mechanism in human disease.
机译:抗肌萎缩蛋白基因的内含子2异常大,在X染色体上延伸157 kb,并且已知含有一个隐性外显子2a。在这里,我们报告说,这个巨大内含子中间的一个核苷酸变化是两个新的外显子的来源。在无症状性肌营养不良症病例的基因组DNA中,在外显子2(T310 + 5591A)的3'端下游5591 bp处发现了一个新的将T变为A核苷酸的点突变。突变鉴定是通过检测两个新的肌营养不良蛋白mRNA来实现的,它们在淋巴细胞的外显子2和3之间包含132个核苷酸或46个核苷酸的插入,而在骨骼肌中包含132个核苷酸的插入。结论是,T310 + 5591A通过在下游132 bp或46 bp处使用两个隐蔽的剪接供体位点,为剪接受体位点创建了一个新的共有序列,导致形成两个新的外显子结构。前者维持肌营养不良蛋白的阅读框架,并预期在肌营养不良蛋白的N末端结构域中插入44个氨基酸,而后者则产生过早的终止密码子。对该患者骨骼肌的免疫组织化学研究显示,肌营养不良蛋白的N末端结构域未染色,但杆和C末端结构域以斑驳且不连续的方式染色,表明框架内mRNA具有功能。通过导致额外外显子结构的单核苷酸变化产生剪接受体位点是人类疾病中的新型分子机制。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号